Initiation of Antiresorptive Drug Treatment during Endocrine Therapy for Breast Cancer—A Retrospective Cohort Study of 161,492 Patients in Germany

Endocrine therapy (ET), which significantly reduces breast cancer (BC) recurrence and mortality rates, is the primary systemic therapy for hormone receptor positive BC. However, in addition to frequently reported TAM- and AI-related side effects, such as hot flashes, arthralgias, and myalgias, treat...

Cur síos iomlán

Sonraí bibleagrafaíochta

Príomhchruthaitheoirí:	Gremke, Niklas, Griewing, Sebastian, Kadys, Arturas, Kostev, Karel, Wagner, Uwe, Kalder, Matthias
Formáid:	Alt
Teanga:	Béarla
Foilsithe / Cruthaithe:	Philipps-Universität Marburg 2023
Ábhair:	endocrine therapy denosumab Medizin bisphosphonates Germany breast cancer tamoxifen antiresorptive therapy aromatase inhibitors Medical sciences Medicine
Rochtain ar líne:	An téacs iomlán mar PDF
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!